Bausch + Lomb Corporation Receives European Ce Mark Approval for Preloaded Luxlife Full Range of Vision Intraocular Lens

Published: 2025-05-07 07:00:00 ET BLCO

Published on 05/07/2025 at 07:00, updated on 05/07/2025 at 08:05

Bausch + Lomb Corporation announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL). The preloaded IOL provides patients with natural, continuous vision, from distance to near. Today's announcement reinforces Bausch + Lomb's commitment to equip cataract surgeons with choices to fit the right lens to the right patient following the recent launches of enVista Envy full range of vision lenses in the United States and Canada and enVista Aspire intermediate-optimized IOLs in Europe.

In a multicenter, comparative clinical study evaluating the LuxLife IOL versus the monofocal LuxGood IOL, patients experienced excellent binocular visual outcomes with LuxLife at all distances, near, intermediate and far. The LuxLife lens also delivered a high level of patient satisfaction with 95.6% of patients reporting corneal astigmatism prior to cataract surgery. During implantation, surgeons can easily select their preferred injection technique with the preloaded LuxLife lens' versatile dual injector system.

LuxLife IOLs will be commercially available in Europe in the coming weeks, followed closely by a toric version of the lens. Submissions for regulatory approvals in other countries are ongoing.